{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["25(1)"],"submitter":["Soff J"],"pubmed_abstract":["<h4>Background</h4>For the treatment of colorectal cancer, the S3-Guideline of the German Guideline Program in Oncology supports clinical decision-making. Centers certified by the German Cancer Society are required to implement the guideline recommendations as comprehensively as possible. When guidelines provide insufficient or ambiguous evidence, heterogeneity of treatment preferences is likely to emerge across individual centers. The aim of this study is to describe the preferences of the centers' tumor boards for treatment decisions when clear, evidence-based guideline recommendations are lacking.<h4>Methods</h4>To investigate the tumor boards' preferences for different treatment options, an anonymous online survey was conducted among 314 certified colorectal cancer centers. The survey "],"journal":["BMC gastroenterology"],"pagination":["700"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12505869"],"repository":["biostudies-literature"],"pubmed_title":["Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and Switzerland."],"pmcid":["PMC12505869"],"pubmed_authors":["Benz S","Pelz A","Kirschner-Schwabe R","Soff J","Wanner A","Dieng S","Fox F","Vehreschild JJ","Witzmann J","Reinacher-Schick A","Gotze A","Hansinger J","Gerken M","Behringer J","Bottcher A","Kim-Wanner SZ","Baum F","onkoFDZ Study Group","Hahn S","Klinkhammer-Schalke M","Borries M","Kowalski C","Hellmund P","Benz SR","Franke B","Lablans M","Kleihues-van Tol K","Zeißig S","Schneider C","Neubert M","Erhard I","Grimm D","Heinrich P","Niedostatek A","Pox CP","Volkel V","Pauler L","Kuscher A","Krolla C","Mertes R","Schmitt J","Kussel T","Reil D","Kirsch F","Abnaof K","Maier D","Lang S","Schoffer O","Horvath E"],"additional_accession":[]},"is_claimable":false,"name":"Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and Switzerland.","description":"<h4>Background</h4>For the treatment of colorectal cancer, the S3-Guideline of the German Guideline Program in Oncology supports clinical decision-making. Centers certified by the German Cancer Society are required to implement the guideline recommendations as comprehensively as possible. When guidelines provide insufficient or ambiguous evidence, heterogeneity of treatment preferences is likely to emerge across individual centers. The aim of this study is to describe the preferences of the centers' tumor boards for treatment decisions when clear, evidence-based guideline recommendations are lacking.<h4>Methods</h4>To investigate the tumor boards' preferences for different treatment options, an anonymous online survey was conducted among 314 certified colorectal cancer centers. The survey ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-04T07:35:54.828Z","creation":"2026-05-06T03:13:08.003Z"},"accession":"S-EPMC12505869","cross_references":{"pubmed":["41057818"],"doi":["10.1186/s12876-025-04183-5"]}}